Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2000
12/07/2000CA2371033A1 Injectable anesthetic formulation
12/07/2000CA2370364A1 Sunscreen composition containing sol-gel microcapsules
12/06/2000EP1057862A2 Polymer film compositions for capsules
12/06/2000EP1057828A2 Trovafloxacin oral suspensions
12/06/2000EP1057483A1 Composition comprising theanine
12/06/2000EP1057478A2 Thermoplastic polymer membranes
12/06/2000EP1057416A2 Soluble isoflavone composition and method for preparing the same
12/06/2000EP1057414A1 Sugar-free hard coatings prepared from liquid mixtures of erythritol and sorbitol
12/06/2000EP1056860A1 High affinity humanized anti-tag-72 monoclonal antibodies
12/06/2000EP1056859A1 High affinity humanized anti-cea monoclonal antibodies
12/06/2000EP1056856A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof
12/06/2000EP1056839A1 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056487A1 Biodegradable shape memory polymers
12/06/2000EP1056477A1 Nanoparticles comprising polyisobutylcyanoacrylate and cyclodextrins
12/06/2000EP1056476A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
12/06/2000EP1056475A1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors
12/06/2000EP1056474A2 Affinity markers for human serum albumin
12/06/2000EP1056473A1 Targeted delivery of biologically active media
12/06/2000EP1056469A1 Novel peptide copolymer compositions
12/06/2000EP1056459A1 Treatment of hiv infections
12/06/2000EP1056445A1 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent
12/06/2000EP1056443A1 Butorphanol sustained release formulations
12/06/2000EP1056419A1 Treatment of female sexual dysfunction
12/06/2000EP0683670B1 Wound-healing compositions containing iodine and a sugar
12/06/2000CN1276009A Electric coated microgranules for stabilizing lactic acid bacteria
12/06/2000CN1275916A Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
12/06/2000CN1275914A Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
12/06/2000CN1275913A Intra-cancer-cell nuclease activator
12/06/2000CN1275910A Therapeutic agents
12/06/2000CN1275908A Preparation of directly mouldable tabletting auxiliary
12/06/2000CN1275408A Technology for preparation of biological dressing material
12/06/2000CN1275335A Stable foam composition
12/06/2000CN1059235C Preparation of living bacillus subtilis and preparation process thereof
12/06/2000CN1059214C Cellulose binding domain
12/06/2000CN1059088C Powder preparation for healing damaged skin
12/05/2000US6156735 Arginine silicate inositol complex and use thereof
12/05/2000US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications
12/05/2000US6156345 Crosslinkable macromers bearing initiator groups
12/05/2000US6156341 Stability; oxidation resistance
12/05/2000US6156339 Forming solution or suspension in solvent of water soluble or water dispersible carrier, filler and pharmaceutically active substance with unacceptable taste in association with lipid; forming discrete units; removing solvent to form unit dosage
12/05/2000US6156338 Method for preparing compositions for transferring nucleic acids
12/05/2000US6156332 Method and composition for masking mineral taste
12/05/2000US6156321 Tissue factor methods and compositions for coagulation and tumor treatment
12/05/2000US6156294 Composition and method for treatment of otitis media
12/05/2000CA2193203C Polymer microparticles for drug delivery
12/05/2000CA2181985C Modified-release metronidazole compositions and methods for making and using same
12/05/2000CA2036089C Prolonged release microcapsules
12/04/2000CA2311112A1 Trovafloxacin oral suspensions
12/04/2000CA2309395A1 Methods for preventing and treating alzheimer's disease
11/2000
11/30/2000WO2000071734A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000WO2000071600A1 Cross-linked polymers that contain condensed alkaline amino acids and method for producing said polymers
11/30/2000WO2000071571A2 Fap-activated anti-tumor compounds
11/30/2000WO2000071566A2 Novel organic anion transport proteins
11/30/2000WO2000071180A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000WO2000071165A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues
11/30/2000WO2000071163A1 Emulsion vehicle for poorly soluble drugs
11/30/2000WO2000071137A1 Electrolyte gels for maintaining hydration and rehydration
11/30/2000WO2000071125A2 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction
11/30/2000WO2000071121A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
11/30/2000WO2000071100A1 Device and method for increasing the transdermal permeation of medicaments
11/30/2000WO2000071099A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
11/30/2000WO2000071098A1 A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same
11/30/2000WO2000071095A2 Release of poorly soluble agents
11/30/2000WO2000071093A1 Niacinamide compositions with reduced tack
11/30/2000WO2000070972A1 New composition
11/30/2000WO2000070949A1 Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
11/30/2000WO2000054745A3 Devices and methods for pain management
11/30/2000WO2000049993A3 Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000041725A3 Therapeutic compositions for metabolic bone disorders or bone metastases
11/30/2000WO2000041694A3 Compositions having improved stability
11/30/2000WO2000041693A3 Compositions having improved delivery of actives
11/30/2000WO2000041692A3 Compositions having improved stability
11/30/2000WO2000041687A3 Composition and methods for administration of water-insoluble paclitaxel derivatives
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/30/2000WO2000040269A3 Pharmaceutical compositions for treatment of diseased tissues
11/30/2000WO2000033814A3 Method for administering agents to the central nervous system
11/30/2000WO2000032772A9 Erythropoietic compounds
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000021572A3 Hydrogels and water soluble polymeric carriers for drug delivery
11/30/2000WO2000011946A3 Prolonged storage of red blood cells
11/30/2000DE19925184A1 Kontinuierliches Verfahren zur Herstellung von morphologisch einheitlichen Mikro- und Nanopartikeln mittels Mikromischer sowie nach diesem Verfahren hergestellte Partikel A continuous process for the production of morphologically uniform micro- and nanoparticles by means of mixer, as well as micro particles produced by this method
11/30/2000DE19924277A1 Zubereitungen von Emulsionstyp W/O mit erhöhtem Wassergehalt mit einem Gehalt an mittelpolaren Lipiden und Siliconemulgatoren und gegebenenfalls kationischen Polymeren Preparations of emulsion W / O type with increased water content with a content of medium-polar lipids and silicone emulsifiers and optionally cationic polymers
11/30/2000DE19923551A1 Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht A pharmaceutical preparation containing the active substance diamorphine and its use in a method for the treatment of opiate addiction
11/30/2000CA2698347A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
11/30/2000CA2374416A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000CA2374296A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000CA2374051A1 Release of poorly soluble agents
11/30/2000CA2373994A1 Emulsion vehicle for poorly soluble drugs
11/30/2000CA2373748A1 Use of chimeric mutational vectors to change endogenous nucleotide sequences in solid tissues
11/30/2000CA2371920A1 Niacinamide compositions with reduced tack
11/30/2000CA2369933A1 Fap-activated anti-tumor compounds
11/29/2000EP1055685A1 Non-antigenic branched polymer conjugates
11/29/2000EP1055424A2 Composition of W/O emulsion type with high water content containing medium-polarity lipids and silicone emulsifiers and optionally cationic polymers
11/29/2000EP1055408A1 Sorbate preserved compositions, process for their manufacture and their use
11/29/2000EP1054998A1 Transglutaminase linkage of agents to tissue
11/29/2000EP1054984A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/29/2000EP1054945A1 Use of detergent mixtures as solutizers
1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 1712